SCHEMBL4835154

SCHEMBL4835154

Cc1ccc(S(=O)(=O)On2c(=O)c3cc4c(=O)n(OS(=O)(=O)c5ccc(C)cc5)c(=O)c4cc3c2=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VDR P11473 2/20 0.53
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 4/20 0.46
HPGD P15428 2/20 0.46
KMT2A Q03164 6/20 0.41
MEN1 O00255 3/20 0.41
GAA P10253 2/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
PKM P14618 2/20 0.40
MMP2 P08253 1/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
CA3 P07451 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA5B Q9Y2D0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17130663 0.88 VDR (0.46) VDRALDH1A1KDM4EHPGDKMT2A
SCHEMBL17130620 0.87 VDR (0.58) VDRALDH1A1KDM4EHPGDKMT2A
SCHEMBL17130676 0.85 MAPT (0.45) VDRKDM4EKMT2AGAAMAPT
SCHEMBL17130665 0.85 VDR (0.46) VDRALDH1A1KDM4EHPGDKMT2A
SCHEMBL4829876 0.84 KMT2A (0.50) VDRALDH1A1KDM4EHPGDKMT2A
SCHEMBL4834642 0.83 GAA (0.48) GAAPKMMMP2CA1CA2
SCHEMBL12534653 0.83 CA2 (0.41) VDRALDH1A1KDM4EHPGDKMT2A
SCHEMBL4836742 0.83 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDKMT2AMEN1
SCHEMBL4835181 0.83 THRB (0.46) VDRALDH1A1KDM4EHPGDKMT2A
SCHEMBL4836943 0.83 CA1 (0.38) VDRALDH1A1KDM4EHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760865-B2 Halogen-free sulphonic acid ester and/or sulphinic acid ester as flame retardant, flame retardant synergists and radical generators in plastics Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-09-19 US disclosed
US-11760865-B2 Halogen-free sulphonic acid ester and/or sulphinic acid ester as flame retardant, flame retardant synergists and radical generators in plastics Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-09-19 US disclosed
US-20200231783-A1 HALOGEN-FREE SULPHONIC ACID ESTER AND/OR SULPHINIC ACID ESTER AS FLAME RETARDANT, FLAME RETARDANT SYNERGISTS AND RADICAL GENERATORS IN PLASTICS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) 2020-07-23 US disclosed
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 VDR 4831/4885ALDH1A1 633/4885KDM4E 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.